News and updates
Last updated on 6 Jan 2021
- 'The HRA is learning fast from the lessons of COVID-19 and listening hard to the needs of the research community' - a blog by Lord Bethell, Minister for Innovation
- 6 Jan 2021
- Author: Lord Bethell, Minister for Innovation
- Review of clinical trials to be accelerated in new fast-track service for non-COVID 19 research
- 6 Jan 2021
- Health Research Authority reacts to Oxford/AstraZeneca vaccine being authorised
- 30 Dec 2020
- A Christmas message to the research community from Teresa Allen, Chief Executive
- 21 Dec 2020
- Author: Teresa Allen
- Praise for Research Ethics Committee members from Chief Medical Officer Chris Whitty
- 21 Dec 2020
- Health Research Authority announces its next Chief Executive
- 8 Dec 2020
An expert in research funding, policy and practice who has dedicated his career to maximising the benefits research offers to society has been appointed as the next Chief Executive of the Health Research Authority. - MedCity chief executive Neelam Patel joins the HRA as Non-Executive Director
- 3 Dec 2020
Neelam Patel, the Chief Executive of MedCity, has been appointed to join the HRA Board. - Vaccine review and reassurance
- 3 Dec 2020
As he fronts a new government campaign to reassure the public about vaccine development, our Chair Professor Sir Terence Stephenson reflects on the role of the HRA in the race from lab to jab. - Fast-track ethics review pilot opens in January
- 3 Dec 2020
A new fast-track research ethics review pilot is opening in January. The pilot will test a rapid research ethics review for global clinical and phase I trials for any disease area. - We’ve updated our amendment tool on IRAS
- 3 Dec 2020
- Call for NHS CTIMP sponsors to join Combined Ways of Working pilot in 2021
- 3 Dec 2020
- Our London office address is changing
- 3 Dec 2020
- Technical Assurances update: MPE/CRE review procedure and generic risk statement
- 3 Dec 2020
- COVID-19 human infection challenge vaccine studies
- 5 Nov 2020
The first COVID-19 human infection challenge vaccine study in the world is planned in the UK. Human infection challenge vaccine studies involve the deliberate infection of healthy volunteers. These studies can be particularly valuable - Removal of commercial organisation information document
- 5 Nov 2020
- New Chief Digital Transformation Officer to help transform digital research systems
- 4 Nov 2020
- Update on health and social care research projects for educational purposes
- 23 Oct 2020
- Learning lessons from ethics review of COVID-19 research
- 1 Oct 2020
- Embracing data-driven healthcare technology
- 1 Oct 2020
- What's next for health research?
- 1 Oct 2020